vBPaeMQR7 is a newly identified lytic bacteriophage with activity against 10 MDR P. aeruginosa isolates, including cephalosporin- and carbapenem-resistant strains, supporting its further development as an alternative antimicrobial agent.
Pu et al. (Tue,) studied this question.